Erste Asset Management Gmb H Exact Sciences Corp Transaction History

Erste Asset Management Gmb H

  • $7.79 Trillion
  • Q1 2025

A detailed history of Erste Asset Management Gmb H transactions in Exact Sciences Corp stock. As of the latest transaction made, Erste Asset Management Gmb H holds 435,272 shares of EXAS stock, worth $23.8 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
435,272
Previous 352,781 23.38%
Holding current value
$23.8 Million
Previous $19.9 Billion 5.22%
% of portfolio
0.24%
Previous 0.24%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$43.04 - $58.51 $3.55 Million - $4.83 Million
82,491 Added 23.38%
435,272 $18.9 Billion
Q4 2024

Feb 10, 2025
SELL
$49.33 - $71.97 $1.94 Million - $2.83 Million
-39,358 Reduced 10.04%
352,781 $19.9 Billion
Q3 2024

Nov 14, 2024
BUY
$42.43 - $70.83 $16.6 Million - $27.8 Million
392,139 New
392,139 $26.5 Billion
Q2 2024

Nov 26, 2024
SELL
$41.33 - $74.26 $735,508 - $1.32 Million
-17,796 Reduced 5.49%
306,132 $13 Billion
Q1 2024

Nov 26, 2024
BUY
$56.27 - $73.77 $2.31 Million - $3.02 Million
41,000 Added 14.49%
323,928 $22.3 Billion
Q4 2023

Nov 26, 2024
BUY
$59.06 - $75.72 $1.48 Million - $1.89 Million
25,000 Added 9.69%
282,928 $21 Billion
Q3 2023

Nov 26, 2024
SELL
$65.94 - $99.04 $6.66 Million - $10 Million
-100,950 Reduced 28.13%
257,928 $17.6 Billion
Q2 2023

Nov 26, 2024
SELL
$62.68 - $95.05 $2.21 Million - $3.35 Million
-35,212 Reduced 11.43%
272,790 $25.6 Billion
Q1 2023

Nov 26, 2024
SELL
$47.19 - $70.77 $706,481 - $1.06 Million
-14,971 Reduced 4.64%
308,002 $20.8 Billion
Q4 2022

Nov 26, 2024
BUY
$30.35 - $53.15 $2.09 Million - $3.66 Million
68,931 Added 23.77%
358,878 $17.8 Billion
Q3 2022

Nov 26, 2024
SELL
$31.97 - $49.37 $2.21 Million - $3.41 Million
-69,166 Reduced 17.64%
322,973 $10.5 Billion
Q2 2022

Nov 26, 2024
BUY
$35.61 - $76.23 $6.52 Million - $14 Million
183,147 Added 171.49%
289,947 $11.5 Billion
Q1 2022

Nov 22, 2024
BUY
$57.56 - $82.54 $1.59 Million - $2.28 Million
27,600 Added 17.7%
183,500 $12.9 Billion
Q4 2021

Nov 22, 2024
SELL
$72.5 - $100.68 $12.3 Million - $17.1 Million
-170,239 Reduced 43.41%
221,900 $17.2 Billion
Q3 2021

Nov 22, 2024
BUY
$90.24 - $124.05 $4.06 Million - $5.58 Million
45,000 Added 40.58%
155,900 $14.8 Billion
Q2 2021

Nov 22, 2024
BUY
$93.66 - $139.27 $1.4 Million - $2.09 Million
15,000 Added 15.64%
110,900 $13.9 Billion
Q1 2021

Nov 22, 2024
SELL
$116.57 - $155.01 $4.43 Million - $5.89 Million
-38,000 Reduced 28.38%
95,900 $12.5 Billion
Q4 2020

Nov 22, 2024
SELL
$99.61 - $142.12 $1.14 Million - $1.62 Million
-11,400 Reduced 7.85%
133,900 $18.1 Billion
Q3 2020

Nov 22, 2024
SELL
$72.92 - $102.01 $18 Million - $25.2 Million
-246,839 Reduced 62.95%
145,300 $14.8 Billion
Q1 2020

Nov 22, 2024
BUY
$37.9 - $104.44 $2.05 Million - $5.64 Million
54,000 Added 81.45%
120,300 $6.99 Billion
Q4 2019

Nov 22, 2024
SELL
$77.66 - $99.74 $25.3 Million - $32.5 Million
-325,839 Reduced 83.09%
66,300 $6.17 Billion
Q3 2019

Nov 22, 2024
SELL
$90.37 - $122.49 $1.08 Million - $1.47 Million
-12,000 Reduced 10.73%
99,800 $9.1 Billion
Q1 2019

Nov 22, 2024
SELL
$61.98 - $96.5 $17.4 Million - $27.1 Million
-280,339 Reduced 71.49%
111,800 $9.58 Billion
Q4 2018

Nov 26, 2024
SELL
$56.04 - $82.66 $16 Million - $23.6 Million
-285,339 Reduced 72.76%
106,800 $6.51 Billion

Others Institutions Holding EXAS

# of Institutions
645
Shares Held
157M
Call Options Held
1.74M
Put Options Held
1.56M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.67B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email